Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression
SUMMARY Tp53 mutations are common in human prostate cancer (CaP), occurring with a frequency of ∼30% and ∼70% in localized and metastatic disease, respectively. In vitro studies have determined several common mutations of Tp53 that have specific gain-of-function properties in addition to loss of fun...
Saved in:
Main Authors: | Ruth L. Vinall (Author), Jane Q. Chen (Author), Neil E. Hubbard (Author), Shola S. Sulaimon (Author), Michael M. Shen (Author), Ralph W. DeVere White (Author), Alexander D. Borowsky (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients.
by: Farhad Babaei, et al.
Published: (2014) -
Germline mutations of TP53 gene can be a key factor in prostate cancer genesis
by: Kawtar Aboulalaa, et al.
Published: (2024) -
Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022) -
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells
by: Daniel Bronder, et al.
Published: (2021) -
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
by: Pinaki Mondal, et al.
Published: (2023)